Johnson & Johnson Sues To Stop Generic Risperdal
A subsidiary of Johnson & Johnson has filed a federal patent infringement lawsuit in an attempt to thwart a Canadian pharmaceutical company's efforts to introduce a generic version of Risperdal, the...To view the full article, register now.
Already a subscriber? Click here to view full article